Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy

236Citations
Citations of this article
85Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A method was developed to quantify prostate metabolite concentrations using 1H high-resolution magic angle spinning (HR-MAS) spectroscopy. T1 and T2 relaxation times (in milliseconds) were determined for the major prostate metabolites and an internal TSP standard, and used to optimize the acquisition and repetition times (TRs) at 11.7 T. At 1°C, polyamines (PAs; T1mean = 100 ± 13, T2mean = 30.8 ± 7.4) and citrate (Cit; T1mean = 237 ± 39, T2mean = 68.1 ± 8.2) demonstrated the shortest relaxation times, while taurine (Tau; T1mean = 636 ± 78, T 2mean = 331 ± 71) and choline (Cho; T1mean = 608 ± 60, T2mean = 393 ± 81) demonstrated the longest relaxation times. Millimolal metabolite concentrations were calculated for 60 postsurgical tissues using metabolite and TSP peak areas, and the mass of tissue and TSP. Phosphocholine plus glycerophosphocholine (PC+GPC), total choline (tCho), lactate (Lac), and alanine (Ala) concentrations were higher in prostate cancer ([PC+GPC]mean = 9.34 ± 6.43, [tCho]mean = 13.8 ± 7.4, [Lac]mean = 69.8 ± 27.1, [Ala] mean = 12.6 ± 6.8) than in healthy glandular ([PC+GPC] mean = 3.55 ± 1.53, P < 0.01; [tCho]mean = 7.06 ± 2.36, P < 0.01; [Lac]mean = 46.5 ± 17.4, P < 0.01; [Ala]mean = 8.63 ± 4.91, P = 0.051) and healthy stromal tissues ([PC+GPC]mean = 4.34 ± 2.46, P < 0.01; [tCho] mean = 7.04 ± 3.10, P < 0.01; [Lac]mean = 45.1 ± 18.6, P < 0.01; [Ala]mean = 6.80 ± 2.95, P < 0.01), while Cit and PA concentrations were significantly higher in healthy glandular tissues ([Cit]mean = 43.1 ± 21.2, [PAs] mean = 18.5 ± 15.6) than in healthy stromal ([Cit] mean = 16.1 ± 5.6, P < 0.01; [PAs]mean = 3.15 ± 1.81, P < 0.01) and prostate cancer tissues ([Cit]mean = 19.6 ± 12.7, P < 0.01; [PAs]mean = 5.28 ± 5.44, P < 0.01). Serial spectra acquired over 12 hr indicated that the degradation of Cho-containing metabolites was minimized by acquiring HR-MAS data at 1°C compared to 20°C. © 2006 Wiley-Liss, Inc.

References Powered by Scopus

Automatic quantitation of localized in vivo <sup>1</sup>H spectra with LCModel

1379Citations
N/AReaders
Get full text

Prostate cancer: Localization with three-dimensional proton MR spectroscopic imaging - Clinicopathologic study

509Citations
N/AReaders
Get full text

Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy

322Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Clinical applications of metabolomics in oncology: A review

631Citations
N/AReaders
Get full text

Metabolomics-based methods for early disease diagnostics

601Citations
N/AReaders
Get full text

Quantitative metabolomics using NMR

515Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Swanson, M. G., Zektzer, A. S., Tabatabai, Z. L., Simko, J., Jarso, S., Keshari, K. R., … Kurhanewicz, J. (2006). Quantitative analysis of prostate metabolites using 1H HR-MAS spectroscopy. Magnetic Resonance in Medicine, 55(6), 1257–1264. https://doi.org/10.1002/mrm.20909

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 32

48%

Researcher 19

29%

Professor / Associate Prof. 11

17%

Lecturer / Post doc 4

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 18

39%

Chemistry 10

22%

Agricultural and Biological Sciences 10

22%

Physics and Astronomy 8

17%

Save time finding and organizing research with Mendeley

Sign up for free